Changes in Fungal Mycobiome, Bacterial Microbiome, and Abundance of Staphylococcus Species After Lebrikizumab Treatment - a Prospective Multicenter Observational Cohort Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The goal of this observational study is to characterize the skin myco- and microbiome of patients with atopic dermatitis before and after initiation of treatment with lebrikizumab. The main questions it aims to answer are: Does the skin mycobiome change with treatment? Does the skin microbiome change with treatment? Does the abundance of Staphylococcus species change with treatment?
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults ≥18 years diagnosed with atopic dermatitis and initiating treatment with lebrikizumab
Locations
Other Locations
Denmark
Dermatology Department Bispebjerg
RECRUITING
Copenhagen
Contact Information
Primary
Ida Marie Nedergaard Thomsen, MD
ida.marie.nedergaard.thomsen.01@regionh.dk
+45 38 63 61 73
Time Frame
Start Date: 2025-06-05
Estimated Completion Date: 2028-05
Participants
Target number of participants: 60
Related Therapeutic Areas
Sponsors
Leads: University Hospital Bispebjerg and Frederiksberg